## Xerophthalmia Staging System (WHO Classification) **Key Point:** Xerophthalmia is staged by the **most advanced** ocular sign present. The WHO classification uses clinical findings to assign the stage, and the highest stage observed determines the patient's classification. ### Clinical Features in This Case - Night blindness (earliest symptom) — present for 2 months - Bitot's spots on conjunctiva bilaterally — pathognomonic foamy/keratinized patches (classically temporal; nasal location is atypical but still consistent with xerophthalmia) - **Mild corneal haze** — represents early corneal xerosis - Low serum retinol (15 µg/dL) — biochemically confirms vitamin A deficiency (<20 µg/dL) ### WHO Xerophthalmia Staging Table | Stage | Clinical Finding | |-------|-----------------| | **XN** | Night blindness only | | **X1A** | Conjunctival xerosis | | **X1B** | Bitot's spots (± conjunctival xerosis) | | **X2** | Corneal xerosis (haze, dryness — no ulceration) | | **X3A** | Corneal ulceration/keratomalacia <1/3 corneal area | | **X3B** | Corneal ulceration/keratomalacia ≥1/3 corneal area | | **XS** | Corneal scar (sequela) | | **XF** | Xerophthalmic fundus | **Clinical Pearl:** The stage assigned is always the **most advanced** sign present. This patient has: 1. Night blindness → XN 2. Bitot's spots → X1B 3. **Mild corneal haze → X2** ← this is the most advanced finding Therefore, the correct stage is **X2 (corneal xerosis)**. ### Why Stage X2 and Not X1A or X1B - **X1A** = conjunctival xerosis alone (no Bitot's spots, no corneal involvement) - **X1B** = Bitot's spots present (but no corneal involvement) - **X2** = corneal xerosis (haze/dryness without ulceration) — **this patient has mild corneal haze**, which by definition places her at Stage X2 - The presence of Bitot's spots (X1B) is superseded by the corneal haze (X2), as staging is determined by the most advanced sign **High-Yield (Park's Textbook of Preventive & Social Medicine):** Corneal xerosis (Stage X2) is a **medical emergency** requiring immediate high-dose vitamin A therapy to prevent progression to keratomalacia (X3A/X3B) and irreversible blindness. Bitot's spots (X1B) are reversible; corneal scarring (XS) is not. **Mnemonic:** **"Most Advanced Sign = Stage Assigned"** — always look for the highest-stage finding to classify xerophthalmia. *Reference: Park's Textbook of Preventive & Social Medicine, 26th edition; WHO/UNICEF/IVACG Task Force — Vitamin A Supplements: A Guide to Their Use in the Treatment and Prevention of Vitamin A Deficiency and Xerophthalmia.* 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.